This article was originally published in The Gray Sheet
Executive SummaryExpansion of European headquarters based in the Swiss state of Vaud is valued at $31 mil. and will more than double production capacity there, the company reports. The move will add 200 new local jobs, bringing the total to 560 by 2006
You may also be interested in...
The last year of the run up to the full implementation of the MDR has been characterized by a flurry of new documents and measures, but industry is adamant that medtech is heading for a crisis that will impact industry and patients alike.
The Chinese government's plan to reduce tariffs it imposed on a slew of US exports is expected to have minimal impact on the overall medtech industry. See what Ralph Ives, AdvaMed's executive VP for global strategy, said about it here.